European Neuropsychopharmacology

Papers
(The H4-Index of European Neuropsychopharmacology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
T58. EXPLORATION OF GENETIC AND CLINICAL HETEROGENEITY IN AUTISM BY CLUSTERING GENES BASED ON BULK AND SINGLE-CELL TRANSCRIPTOMIC DATA383
Norepinephrine system dysconnectivity in major depressive disorder: the effect of short term SSRI treatment107
11. ESTABLISHING THE MOLECULAR FOUNDATION OF BRAIN ANATOMY IN LIVING INDIVIDUALS99
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER95
T84. AN INVESTIGATION ON GENETIC MECHANISMS UNDER CLINICAL HETEROGENEITY IN SCHIZOPHRENIA92
F41. AMBER: ANTIDEPRESSANT MEDICATIONS: BIOLOGY, EXPOSURE AND RESPONSE77
T56. DIP2A, HIGHLY EXPRESSED GENE IN THE CEREBELLUM, IS ASSOCIATED WITH A WIDE RANGE OF PSYCHIATRIC SYMPTOMS (DELAYED SPEECH, AUTISM SPECTRUM DISORDER AND SPECIFIC LEARNING DISABILITIES)71
T13. GENETIC ASSOCIATIONS OF ICD-DERIVED PSYCHIATRIC DIAGNOSES WITH SELF-REPORTED MENTAL HEALTH PHENOTYPES IN THE UK BIOBANK70
F8. THE DEVELOPMENTAL LANDSCAPE OF NEUROPSYCHIATRIC GENOMICS IN AFRICA66
T78. GENE-ENVIRONMENT INTERACTION STUDY ON THE CORRELATES FOR PSYCHOTIC EXPERIENCES IN THE UK BIOBANK62
F97. DIFFERENTIAL EXPRESSION OF MICRORNAS UPON IN VITRO LITHIUM AND VALPROATE EXPOSURE TO BIPOLAR DISORDER PATIENTS-DERIVED LCLS60
41. CHARACTERIZING FUNCTIONAL CONVERGENCE OF COMMON POLYGENIC VARIATION IN NEUROPSYCHIATRIC DISORDER RISK GENES60
T100. CHILD SUBCORTICAL BRAIN VOLUMES: THE INTERACTION BETWEEN GENETIC RISK AND MATERNAL PSYCHOLOGICAL DISTRESS DURING PREGNANCY60
F75. PREDICTION OF TREATMENT-RESISTANT SCHIZOPHRENIA USING REAL-WORLD DATA AND MULTIMODAL ANALYTICAL TOOLS60
85. DETECTION OF PLACENTAL SCHIZOPHRENIA RISK GENES54
1. DEVELOPMENTAL TRAJECTORIES OF DNA METHYLATION IN NEURAL CELL POPULATIONS IN HUMAN CORTEX AND LINKS TO NEURODEVELOPMENTAL DISORDERS53
2. ENRICHMENT OF RARE, DAMAGING VARIANTS IN SCHIZOPHRENIA-RELATED GENES IN INTELLECTUAL DISABILITY PATIENTS WITH PSYCHOTIC DISORDERS50
T35. SHARED GENETIC LIABILITY FOR ALCOHOL CONSUMPTION, ALCOHOL PROBLEMS, AND SUICIDAL BEHAVIOR: EVALUATING THE ROLE OF IMPULSIVITY49
T33. USING GENOMICS TO AID EARLY DIFFERENTIAL DIAGNOSIS BETWEEN BIPOLAR DISORDER AND MAJOR DEPRESSION49
T59. A GENOME-WIDE ASSOCIATION STUDY OF EATING DISORDER SYMPTOMS BASED ON THE SCOFF QUESTIONNAIRE48
T67. ASSOCIATIONS BETWEEN METHYLATION AGE AND BRAIN AGE IN LATE ADOLESCENCE46
37. CONVERGENT IMPACT OF SCHIZOPHRENIA RISK GENES45
Opioid use and misuse in Europe: COVID-19 new challenges?44
Editorial Board44
Muscle and the mind: The combination of creatine and exercise for depression41
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial41
A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder40
BEYOND STANDARD GWAS IN BIPOLAR DISORDER: INTEGRATIVE FINE-MAPPING, MULTI-TRAIT, AND EPIGENETIC APPROACHES FOR CAUSAL VARIANT DISCOVERY37
M70. INTRODUCTION TO THE MOUNT SINAI MILLION SCHIZOPHRENIA DISCOVERIES PROGRAM (MSM-SCZ)37
T39. POLYGENIC RISK AND CHILDHOOD TRAUMA AS PREDICTORS OF SUICIDE RISK IN BIPOLAR DISORDER37
W2. MULTIVARIABLE GENE ENVIRONMENT INTERACTION IN THE PREDICTION OF PROSOCIAL BEHAVIOR36
W87. PREDICTORS OF ALCOHOL CONSUMPTION: THE ROLE OF GENETICS AND IMPULSIVITY FROM ADOLESCENCE TO ADULTHOOD35
17. LANDSCAPE SURVEY OF 8853 CLINICAL TRIALS IN DEPRESSION TO IDENTIFY NEW TREATMENT RESPONSE PHARMACOGENETIC STUDIES33
0.15264892578125